Skip to main content

Table 5 Results of the tree pollen study

From: Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy

  Placebo 1000 UA
No reaction Reaction P No reaction Reaction P
Mean SD Mean SD Mean SD Mean SD
TCS 14 11.90 7.20 12.62 8.14 0.85 8.50 6.28 13.15 7.19 0.02
TCS 30 9.84 6.90 10.96 6.96 0.46 7.79 5.52 11.03 6.01 0.04
TCS 60 9.15 6.43 9.27 5.88 0.73 7.36 5.31 9.67 5.33 0.10
RTSS 14 7.10 3.11 6.96 4.16 0.75 4.64 2.78 6.72 3.47 0.02
RTSS 30 5.93 2.94 6.30 3.76 0.83 4.35 2.58 5.75 3.08 0.05
RTSS 60 5.55 2.54 5.49 3.03 0.90 3.94 2.40 5.17 2.66 0.07
TRMS 14 4.81 5.66 5.66 5.30 0.30 3.86 4.70 6.43 5.17 0.08
TRMS 30 3.91 5.16 4.66 4.52 0.26 3.44 4.19 5.29 4.38 0.10
TRMS 60 3.60 4.89 3.78 4.06 0.42 3.42 3.81 4.50 4.03 0.26
Well days 14.17 14.94 15.75 17.85 0.88 22.76 18.73 15.08 16.01 0.16
Efficacy 2.56 0.62 2.06 0.79 0.02 2.29 0.85 2.05 0.78 0.24
Satisfaction 2.11 0.90 1.97 0.85 0.49 2.18 0.81 1.92 1.01 0.42
Recommendation 2.17 0.79 2.33 0.86 0.32 2.41 0.71 2.15 0.93 0.36
  1. RTSS rhinoconjunctivitis total symptom score, SD standard deviation, TCS total combined score, TRMS total rescue medication score, UA unit of allergen